NMR spectroscopy for discovery and quantitation of biomarkers of disease in human bile

Bioanalysis

Volumn 3, Issue 16, 2011, Pages 1877-1890

  Nagana Gowda, G A ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; BILE ACID CONJUGATE; CHENODEOXYCHOLIC ACID; CHOLESTEROL; CHOLIC ACID; DEOXYCHOLIC ACID; GLYCOCHENODEOXYCHOLIC ACID; GLYCOCHOLIC ACID; GLYCODEOXYCHOLIC ACID; LACTIC ACID; PHOSPHATIDYLCHOLINE; TAUROCHENODEOXYCHOLIC ACID; TAUROCHOLIC ACID; TAURODEOXYCHOLIC ACID; TAUROURSODEOXYCHOLIC ACID;

ALCOHOL LIVER CIRRHOSIS; BILE; BILE DUCT CANCER; BILE LEVEL; CARBON NUCLEAR MAGNETIC RESONANCE; COMMON BILE DUCT CYST; DIAGNOSTIC VALUE; DISEASE MARKER; GAS LIQUID CHROMATOGRAPHY; HEPATITIS C; HEPATOBILIARY DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER CELL CARCINOMA; METABOLITE; METABOLOMICS; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; PANCREAS CANCER; PRIMARY SCLEROSING CHOLANGITIS; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; REVIEW;

BILE; BILIARY TRACT DISEASES; BIOLOGICAL MARKERS; FEMALE; HUMANS; LIVER DISEASES; MALE; METABOLOME; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR;

EID: 80052469154     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.152     Document Type: Review

References (76)

1. Asiago V, Alvarado L, Shanaiah N et al. Early detection of recurrent breast cancer using metabolite profiling, Cancer Res. 70(21), 8309-8318 (2010).
2. Davis VW, Bathe OF, Schiller DE, Slupsky CM, Sawyer MB. Metabolomics and surgical oncology: potential role for small molecule biomarkers. J. Surg Oncol. 103(5), 451-459 (2011).
3. Fiehn O. Metabolomics - the link between genotypes and phenotypes. Plant Mol. Biol. 48(1-2), 155-171 (2002). (Pubitemid 34128498)
4. Gerszten RE, Wang TJ. The search for new cardiovascular biomarkers. Nature 451(7181), 949-952 (2008). (Pubitemid 351301751)
5. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29(11), 1181-1189 (1999).
6. Nagana Gowda GA, Zhang S, Gu H, Asiago V, Shanaiah N, Raftery D. Metabolomics-based methods for early disease diagnostics. Exp. Rev. Mol. Diagn. 8(5), 617-633 (2008).
7. Serkova NJ, Niemann CU. Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics. Exp. Rev. Mol. Diagn. 6(5), 717-731 (2006). (Pubitemid 44525597)
8. Sreekumar A, Poisson LM, Rajendiran TM et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457(7231), 910-914 (2009).
9. Raftery D, Nagana Gowda GA. An approaching new wave of multicomponent biomarker diagnostics? J. Urol. 179(6), 2089-2090 (2008).
10. Wishart DS, Knox C, Guo AC et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 37(Database issue), D603-D610 (2009).
11. Psychogios N, Hau DD, Peng J et al. The human serum metabolome. PLoS One 6(2), e16957 (2011).
12. Holmes E, Wilson ID, Nicholson JK. Metabolic phenotyping in health and disease. Cell 134(5), 714-717 (2008).
13. Burns MA, He W, Wu CL, Cheng LL. Quantitative pathology in tissue MR spectroscopy based human prostate metabolomics. Technol. Cancer. Res. Treat. 3(6), 591-598 (2004). (Pubitemid 40023549)
14. Denkert C, Budczies J, Kind T et al. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res. 66, 10795-10804 (2006). (Pubitemid 44876975)
15. Nagana Gowda GA. Human bile as a rich source of biomarkers for hepatopancreatobiliary cancers. Biomarkers Med. 4(2). 299-314 (2010).
16. Nagana Gowda GA, Shanaiah N, Cooper A, Maluccio M, Raftery D. Visualization of bile homeostasis using 1H NMR spectroscopy as a route for assessing liver cancer. Lipids 44, 27-35 (2009).
17. Sjóvall J. Fifty years with bile acids and steroids in health and disease. Lipids 39(8), 703-722(2004). (Pubitemid 39610516)
18. Hofmann AF. The continuing importance of bile acids in liver and intestinal diseases. Arch. Intern. Med. 159, 2647-2658 (1999).
19. Hofmann AF. Bile acids: trying to understand their chemistry and biology with the hope of helping patients. Hepatology 49(5), 1403-1418 (2009).
20. Nagana Gowda GA, Ijare OB, Shanaiah N, Bezabeh T. Combining NMR spectroscopy and mass spectrometry in biomarker discovery. Biomark. Med. 3(3), 307-322 (2009).
21. Griffitts J, Tesiram YA, Reid GE, Saunders D, Floyd RA, Towner RA. In vivo magnetic resonance spectroscopy (MRS) assessment of altered fatty acyl unsaturation in liver tumor formation of a TGFa/c-myc transgenic mouse model. J. Lipid Res. 50(4), 611-622 (2009).
22. Kaplan O, Kushnir T, Askenazy N, Knubovets T, Navon G. Role of nuclear magnetic resonance spectroscopy (MRS) in cancer diagnosis and treatment: 31P, 23Na, and 1H MRS studies of three models of pancreatic cancer. Cancer Res. 57(8), 1452-1459 (1997). (Pubitemid 27175560)
23. Nagana Gowda GA. Opportunities and challenges in NMR spectroscopy for early diagnostics of hepatobiliary diseases (Chapter 5). In: Future Directions of Magnetic Resonance. Springer Verlag (2009).
24. Khan SA, Cox IJ, Hamilton G, Thomas HC, Taylor-Robinson SD. In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications. Liver Int. 25(2), 273-281 (2005).
25. Ijare OB, Smith ICP, Mohajeri S, Bezabeh T. Magnetic Resonance spectroscopy (MRS) of bile in the diagnosis of hepatopancreaticobiliary diseases: past, present and future. In: Future Directions of Magnetic Resonance. Springer Verlag (2009).
26. Mohajeri S, Bezabeh T, King SB et al. In vivo 1H MRS of human gallbladder bile using an optimized 16-channel phased array at 3T. Proc. Int. Soc. Magn. Reson. Med. 19, 870 (2011).
27. Bloch CA, Watkins JB. Determination of conjugated bile acids in human bile and duodenal fluid by reverse phase high-performance liquid chromatography. J. Lipid Res. 19, 510-513 (1978). (Pubitemid 8356054)
28. Budai K, Javitt NB. Bile acid analysis in biological fluids: a novel approach. J. Lipid Res. 38, 1906-1912 (1997). (Pubitemid 27411282)
29. Guldutuna S, You T, Kurts W, Leuschner U. High-performance liquid chromatographic determination of free and conjugated bile acids in serum, liver biopsies, bile, gastric juice and feces by flouorescene labeling. Clin. Chim. Acta 214, 195-207 (1993). (Pubitemid 23102290)
30. Perwaiz S, Tuchweber B, Mignault D, Gilat T, Yousef IM. Determination of bile acids in biological fluids by liquid chromatography- electrospray tandem mass spectrometry. J. Lipid Res. 42, 114-119 (2001). (Pubitemid 32142866)
31. Tietz PS, Thistle JL, Miller LJ, LaRusso NF. Development and validation of a method for measuring the glycine and taurine conjugates of bile acids in bile by high-performance liquid chromatography. J. Chromatogr. 336(2), 249-257 (1984). (Pubitemid 15157579)
32. Wildgrube HJ, Stockhausen H, Petri J, Fussel U, Lauer H. Naturally occurring conjugated bile acids, measured by high performance liquid chromatography, in human, dog, and rabbit bile. J. Chromatogr. 353, 207-213 (1986). (Pubitemid 16016344)
33. Sequeira SS, Parkes HJ, Ellul JPM, Murphy GM. In vitro determination by 1H-NMR studies that bile with shorter nucleation times contain cholesterol-enriched vesicles. Biochim. Biophys. Acta 1256, 360-366 (1995).
34. Jones ML, Chen H, Ouyang W, Metz T, Prakash S. Methods for bile acid determination by high performance liquid chromatography. J. Med. Sci. 23, 277-280 (2003).
35. Perwaiz S, Tuchweber B, Mignault D, Gilat T, Yousef IM. Determination of bile acids in biological fluids by liquid chromatography-electrospray tandem mass spectrometry. J. Lipid. Res. 42(1), 114-119 (2001). (Pubitemid 32142866)
36. Mim D, Hercules D. Quantification of bile acids directly from plasma by MALDI-TOF-MS. Anal. Bioanal. Chem. 378, 1322-1326 (2004). (Pubitemid 40877730)
37. Dominguez C, Kreuzer CS, Bornet O, Kerfelec B, Chapus C, Guerlesquin F. Interactions of bile salt micelles and colipase studied through intermolecular nOes. FEBS Letters. 482, 109-112 (2000).
38. Maili Liu R, Farrant D, Lindon JC, Nicholson JK. Two-dimensional 1H-1H and 13C-1H maximum-quantum correlation NMR spectroscopy with application to the assignment of the NMR spectra of the bile salt sodium taurocholate. Magn. Reson. Chem. 33, 212-219 (1995).
39. Leibfritz D, Roberts JD. Nuclear magnetic resonance spectroscopy. Carbon-13 spectra of cholic acids and hydrocarbons included in sodium desoxycholate solutions. J. Am. Chem. Soc. 95, 4996-5003 (1973).
40. Small DM, Penkell SA, Chapman D. Studies on simple and mixed bile salt micelles by nuclear magnetic resonance spectroscopy. Biochim. Biophys. Acta. 176, 178-189 (1969).
41. Waterhous DV, Bernes S, Muccio DD. Nuclear magnetic resonance spectroscopy of bile acids. Development of two-dimensional NMR methods for the elucidation of proton resonance assignments for five common hydroxylated bile acids, and their parent bile acid, 5b-cholanoic acid. J. Lipid Res. 26, 1068-1078 (1985). (Pubitemid 16258291)
42. Bernes S, Geckle JM. High resolution nuclear magnetic resonance spectroscopy of bile salts: individual proton assignments for sodium cholate in aqueous solution at 400MHz. J. Lipid Res. 23, 161-170 (1982). (Pubitemid 12112624)
43. Campredon M, Quiroa A, Thevand A, Allouche A, Pouzard G. NMR studies of bile acid salts: 2D NMR studies of aqueous and methanolic solutions of sodium cholate and deoxycholate. Magn. Reson. Chem. 24, 624-629 (1986).
44. Ijare OB, Somashekar BS, Jadegoud Y, Nagana Gowda GA. 1H and 13C NMR Characterization and stereochemical assignments of bile acids in aqueous media. Lipids 40, 1031-1041 (2005).
45. Nagana Gowda GA, Ijare OB, Somashekar BS, Sharma A, Kapoor VK, Khetrapal CL. Single step analysis of individual conjugated bile acids in human bile using 1H NMR spectroscopy. Lipids 41, 591-603 (2006). (Pubitemid 44300151)
46. Ishikawa H, Nakashima T, Inaba K et al. Proton magnetic resonance assay of total and taurine conjugated bile acids in bile. J. Lipid Res. 40, 1920-1924(1999). (Pubitemid 29477263)
47. Ellul JPM, Murphy GM, Parkes HG, Slapa RZ, Dowling RH. Nuclear magnetic resonance spectroscopy to determine the micellar cholesterol in human bile. FEBS Lett. 300, 30-32 (1992).
48. Little TE, Lee SP, Madani H, Kaler EW, Chinn K. Interconversions of lipid aggregates in rat and model bile. Am. J. Physiol. (Gaastrointest. Liver. Physiol. 23), 260, G70-G79 (1991).
49. Donovan JM, Jackson AA. Accurate separation of biliary aggregates requires the correct intermixed micellar/intervesicular bile salt concentration. Hepatology 27, 641-648 (1998). (Pubitemid 28103536)
50. Srivastava M, Jadegoud Y, Nagana Gowda GA, Sharma A, Kapoor VK, Khetrapal CL. An accurate method for cholesterol analysis in bile. Anal. Letts. 38, 2135-2141 (2005). (Pubitemid 41540891)
51. Nagana Gowda GA, Somashekar BS, Ijare OB, Sharma A, Kapoor VK, Khetrapal CL. One step analysis of major bile metabolites in human bile using 1H NMR spectroscopy. Lipids 41, 577-589 (2006). (Pubitemid 44300150)
52. Ijare OB, Somashekar BS, Nagana Gowda GA et al. Quantification of glycine and taurine conjugated bile acids in human bile using 1H NMR spectroscopy. Magn. Reson. Med. 53(6), 1441-1446 (2005). (Pubitemid 40734666)
53. Wildgrube HJ, Stockhausen H, Petri J, Füssel U, Lauer H. Naturally occurring conjugated bile acids, measured by high-performance liquid chromatography, in human, dog, and rabbit bile. J. Chromatogr. 353, 207-213 (1986). (Pubitemid 16016344)
54. Ijare OB, Bezabeh T, Albiin N et al. Simultaneous quantification of glycine- and taurine-conjugated bile acids, total bile acids, and choline containing phospholipids in human bile using 1H NMR spectroscopy. J. Pharm. Biomed. Anal. 53(3), 667-673 (2010).
55. Duarte IF, Legido-Quigley C, Parker DA et al. Identification of metabolites in human hepatic bile using 800 MHz 1H NMR spectroscopy, HPLC-NMR/MS and UPLC-MS. Mol. Biosyst. 5(2), 180-190. (2009).
56. Blonski W, Reddy KR. Hepatitis C virus infection and hepatocellular carcinoma. Clin. Liver. Dis. 12(3), 661-674 (2008). (Pubitemid 351952471)
57. Cox IJ, Sharif A, Cobbold JF, Thomas HC, Taylor-Robinson SD. Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease. World J. Gastroenterol. 12(30), 4773-4783 (2006). (Pubitemid 44323200)
58. Khan SA, Cox IJ, Thillainayagam AV, Bansi DS, Thomas HC, Taylor-Robinson SD. Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer. Eur. J. Gastroenterol. Hepatol. 17(7), 733-738 (2005). (Pubitemid 40896419)
59. Nishijima T, Nishina M, Fujiwara K. Measurement of lactate levels in serum and bile using proton nuclear magnetic resonance in patients with hepatobiliary diseases: its utility in detection of malignancies. Jpn. J. Clin. Oncol. 27(1), 13-17 (1997). (Pubitemid 127516278)
60. Cox IJ, Bell JD, Peden CJ et al. In vivo and in vitro 31P magnetic resonance spectroscopy of focal hepatic malignancies. NMR Biomed. 5(3), 114-120 (1992).
61. Cox IJ, Menon DK, Sargentoni J et al. Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques. J. Hepatol. 14(2-3), 265-275 (1992).
62. Francis IR, Chenevert TL, Gubin B et al. Malignant hepatic tumors: P-31 MR spectroscopy with one-dimensional chemical shift imaging. Radiology 180(2), 341-344 (1991).
63. Albiin N, Smith IC, Arnelo U et al. Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis. Acta Radiol. 49(8), 855-862 (2008).
64. Park JY, Park BK, Ko JS, Bang S, Song SY, Chung JB. Bile acid analysis in biliary tract cancer. Yonsei Med. J. 47(6), 817-825 (2006). (Pubitemid 46029640)
65. Bezabeh T, Ijare OB, Albiin N, Arnelo U, Lindberg B, Smith IC. Detection and quantification of d-glucuronic acid in human bile using 1H NMR spectroscopy: relevance to the diagnosis of pancreatic cancer. Magn. Reson. Mater. Phy. 22, 267-275 (2009).
66. Ijare OB, Bezabeh T, Albiin N et al. Absence of glycochenodeoxycholic acid (GCDCA) in human bile is an indication of cholestasis: a 1H MRS study. NMR Biomed. 22(5), 471-479(2009).
67. Bala L, Tripathi P, Bhatt G et al. 1H and 31P NMR studies indicate reduced bile constituents in patients with biliary obstruction and infection. NMR Biomed. 22(2), 220-228 (2009).
68. Melendez HV, Ahmadi D, Parkes HG, Rela M, Murphy G, Heaton N. Proton transplantation. Nuclear magnetic resonance analysis of hepatic bile from donors and recipients in human liver transplantation. Transplantation 72(5), 855-860 (2001). (Pubitemid 32879858)
69. Paczkowska A, Toczyowska B, Nyckowski P. High-resolution 1H nuclear magnetic resonancespectroscopy analysis of bile samples obtained from a patient after orthotopic liver transplantation: new perspectives. Transplant. Proc. 35(6), 2278-2280 (2003). (Pubitemid 37194390)
70. Nagana Gowda GA, Shanaiah N, Cooper A, Maluccio M, Raftery D. Bile acids conjugation in human bile is not random: new insights from 1H NMR spectroscopy at 800 MHz. Lipids 44(6), 527-535 (2009).
71. Shanaiah N, Desilva A, Nagana Gowda GA, Raftery MA, Hainline BE, Raftery D. Metabolite class selection of amino acids in body fluids using chemical derivatization and their enhanced 13C NMR. Proc. Natl Acad. Sci. USA 104(28), 11540-11544 (2007). (Pubitemid 47175048)
72. Ye T, Mo H, Shanaiah N, Nagana Gowda GA, Zhang S, Raftery D. Chemoselective 15N tag for sensitive and high-resolution nuclear magnetic resonance profiling of the carboxyl-containing metabolome. Anal. Chem. 81(12), 4882-4888 (2009).
73. Ye T, Zhang S, Mo H, Tayyari F, Nagana Gowda GA, Raftery D. 13C-formylation for improved NMR profiling of amino metabolites in biofluids. Anal. Chem. 82(6), 2303-2309 (2010).
74. Nagana Gowda GA, Tayyari F, Ye T et al. Quantitative analysis of blood plasma metabolites using isotope enhanced NMR methods. Anal. Chem., 82(21), 8983-8990 (2010).
75. Prescot AP, Collins DJ, Leach MO, Dzik-Jurasz AS. Human gallbladder bile: noninvasive investigation in vivo with single-voxel 1H MR spectroscopy. Radiology 229(2), 587-592 (2003). (Pubitemid 37310851)
76. Künnecke B, Bruns A, von Kienlin M. Non-invasive analysis of gallbladder bile composition in cynomolgus monkeys using in vivo 1H magnetic resonance spectroscopy. Biochim. Biophys. Acta 1771(4), 544-549 (2007). (Pubitemid 46518275)